These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22129594)

  • 41. Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABAA receptors and shows hypnotic effects.
    Cho S; Kim S; Jin Z; Yang H; Han D; Baek NI; Jo J; Cho CW; Park JH; Shimizu M; Jin YH
    Biochem Biophys Res Commun; 2011 Oct; 413(4):637-42. PubMed ID: 21945440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic and functional conservation of sedative-hypnotic targets in the zebrafish.
    Renier C; Faraco JH; Bourgin P; Motley T; Bonaventure P; Rosa F; Mignot E
    Pharmacogenet Genomics; 2007 Apr; 17(4):237-53. PubMed ID: 17496723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-HT1A, 5-HT2, and GABAB receptors interact to modulate neurotransmitter release probability in layer 2/3 somatosensory rat cortex as evaluated by the paired pulse protocol.
    Torres-Escalante JL; Barral JA; Ibarra-Villa MD; Pérez-Burgos A; Góngora-Alfaro JL; Pineda JC
    J Neurosci Res; 2004 Oct; 78(2):268-78. PubMed ID: 15378508
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
    Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
    Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The positive allosteric GABAB receptor modulator rac-BHFF enhances baclofen-mediated analgesia in neuropathic mice.
    Zemoura K; Ralvenius WT; Malherbe P; Benke D
    Neuropharmacology; 2016 Sep; 108():172-8. PubMed ID: 27108932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
    Sullivan SK; Petroski RE; Verge G; Gross RS; Foster AC; Grigoriadis DE
    J Pharmacol Exp Ther; 2004 Nov; 311(2):537-46. PubMed ID: 15256540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.
    Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF
    Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile.
    Kalinichev M; Donovan-Rodriguez T; Girard F; Riguet E; Rouillier M; Bournique B; Haddouk H; Mutel V; Poli S
    Br J Pharmacol; 2014 Nov; 171(21):4941-54. PubMed ID: 24923436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo effectiveness of CGP7930, a positive allosteric modulator of the GABAB receptor.
    Carai MA; Colombo G; Froestl W; Gessa GL
    Eur J Pharmacol; 2004 Nov; 504(3):213-6. PubMed ID: 15541424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
    Agabio R; Colombo G
    Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of alcohol self-administration by positive allosteric modulators of the GABAB receptor in rats: lack of tolerance and potentiation of baclofen.
    Maccioni P; Vargiolu D; Thomas AW; Malherbe P; Mugnaini C; Corelli F; Leite-Morris KA; Gessa GL; Colombo G
    Psychopharmacology (Berl); 2015 May; 232(10):1831-41. PubMed ID: 25420609
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors.
    Urwyler S; Gjoni T; Kaupmann K; Pozza MF; Mosbacher J
    Eur J Pharmacol; 2004 Jan; 483(2-3):147-53. PubMed ID: 14729102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABA
    Kalinichev M; Girard F; Haddouk H; Rouillier M; Riguet E; Royer-Urios I; Mutel V; Lütjens R; Poli S
    Neuropharmacology; 2017 Mar; 114():34-47. PubMed ID: 27889489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. KK-92A, a novel GABA
    Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A
    Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of (R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one as a positive allosteric modulator of GABAB receptors.
    Malherbe P; Masciadri R; Norcross RD; Knoflach F; Kratzeisen C; Zenner MT; Kolb Y; Marcuz A; Huwyler J; Nakagawa T; Porter RH; Thomas AW; Wettstein JG; Sleight AJ; Spooren W; Prinssen EP
    Br J Pharmacol; 2008 Jun; 154(4):797-811. PubMed ID: 18536733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of the γ-Aminobutyric Acid Type B (GABA(B)) Receptor by Agonists and Positive Allosteric Modulators.
    Brown KM; Roy KK; Hockerman GH; Doerksen RJ; Colby DA
    J Med Chem; 2015 Aug; 58(16):6336-47. PubMed ID: 25856547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological characterisation of a cell line expressing GABA B1b and GABA B2 receptor subunits.
    Hirst WD; Babbs AJ; Green A; Minton JA; Shaw TE; Wise A; Rice SQ; Pangalos MN; Price GW
    Biochem Pharmacol; 2003 Apr; 65(7):1103-13. PubMed ID: 12663046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arylalkylamines are a novel class of positive allosteric modulators at GABA(B) receptors in rat neocortex.
    Kerr DI; Ong J; Puspawati NM; Prager RH
    Eur J Pharmacol; 2002 Sep; 451(1):69-77. PubMed ID: 12223231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppression of GABA(B) receptor function in vivo by disulfide reducing agent, DL-dithiothreitol (DTT).
    Carai MA; Vacca G; Serra S; Colombo G; Froestl W; Gessa GL
    Psychopharmacology (Berl); 2004 Jul; 174(2):283-90. PubMed ID: 14760512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ontogenetic development of GABA(B)-receptor signaling cascade in plasma membranes isolated from rat brain cortex; the number of GABA(B)-receptors is high already shortly after the birth.
    Kagan D; Dlouhá K; Roubalová L; Svoboda P
    Physiol Res; 2012; 61(6):629-35. PubMed ID: 23098656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.